tiprankstipranks
Trending News
More News >
Vir Biotechnology (VIR)
NASDAQ:VIR
US Market

Vir Biotechnology (VIR) Income Statement

Compare
1,516 Followers

Vir Biotechnology Income Statement

Last quarter (Q4 2025), Vir Biotechnology's total revenue was $64.07M, an increase of 417.78% from the same quarter last year. In Q4, Vir Biotechnology's net income was $-42.92M. See Vir Biotechnology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 68.56M$ 74.20M$ 86.18M$ 1.62B$ 1.10B
Gross Profit
$ 56.85M$ -404.44M$ -486.65M$ 994.83M$ 581.54M
Operating Expenses
$ 524.87M$ 182.72M$ 197.66M$ 161.76M$ 160.79M
Depreciation and Amortization
$ 11.68M$ 14.56M$ 19.45M$ 6.78M$ 5.81M
EBITDA
$ -426.09M$ -508.91M$ -641.64M$ 839.85M$ 426.56M
Operating Income
$ -468.02M$ -587.16M$ -684.30M$ 833.07M$ 420.75M
Other Income/Expenses
$ 30.25M$ 64.06M$ 56.11M$ -78.79M$ 129.05M
Pretax Income
$ -437.77M$ -523.11M$ -628.19M$ 754.28M$ 549.80M
Net Income
$ -437.99M$ -521.96M$ -615.06M$ 515.84M$ 528.58M
Per Share Metrics
Basic EPS
$ -3.16$ -3.83$ -4.59$ 3.89$ 4.07
Diluted EPS
$ -3.16$ -3.83$ -4.59$ 3.83$ 3.96
Weighted Average Shares Outstanding
138.52M 136.25M 134.13M 132.61M 129.88M
Weighted Average Shares Outstanding (Diluted)
138.52M 136.25M 134.13M 134.81M 133.44M
Currency in USD

Vir Biotechnology Earnings and Revenue History